Compound Detail
CHEMBL1236682
REFAMETINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1236682 |
| Name | REFAMETINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | RDSACQWTXKSHJT-NSHDSACASA-N |
9
Targets
11
Activities
2
Assay Types
0
PK Parameters
20
Publications
12
Known Names
4
Indications
2
Mechanisms
Molecular Properties
572.3
MW (Da)
3.48
ALogP
6
HBA
4
HBD
107.9
PSA (Ų)
0.34
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase 1 inhibitor | INHIBITOR | Dual specificity mitogen-activated protein kinase kinase 1 | ✓ | ✓ |
| Dual specificity mitogen-activated protein kinase kinase 2 inhibitor | INHIBITOR | Dual specificity mitogen-activated protein kinase kinase 2 | ✓ | ✓ |
Indications
Biliary Tract Neoplasms Carcinoma, Hepatocellular Neoplasms Neoplasms
Activity Summary
Kd 7 meas. best 7.44
IC50 4 meas. best 7.72
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Mitogen-activated protein kinase 10 CHEMBL2637 | Kd | 7.44 | 7.44 | 36.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 CHEMBL2964 | IC50 | 7.33 | 7.33 | 47.0 | 1 |
| Influenza A virus CHEMBL613740 | IC50 | 7.22 | 7.22 | 60.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | Kd | 6.89 | 6.89 | 130.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 CHEMBL2964 | Kd | 6.75 | 6.75 | 176.0 | 1 |
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | Kd | 6.36 | 6.36 | 439.0 | 1 |
| AarF domain-containing protein kinase 1 CHEMBL4105885 | Kd | 6.11 | 6.11 | 778.0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 CHEMBL2453 | Kd | 5.55 | 5.55 | 2817.0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 CHEMBL2393 | Kd | 4.75 | 4.75 | 17783.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-2B | 1 |
| 29191878 | 10.1126/science.aan4368 | RAC-gamma serine/threonine-protein kinase | 1 |
| 29191878 | 10.1126/science.aan4368 | RAC-beta serine/threonine-protein kinase | 1 |
| 29191878 | 10.1126/science.aan4368 | Adenylate kinase 2, mitochondrial | 1 |
| 29191878 | 10.1126/science.aan4368 | Beta-adrenergic receptor kinase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Adenosine kinase | 1 |
| 29191878 | 10.1126/science.aan4368 | Atypical kinase COQ8A, mitochondrial | 1 |
| 29191878 | 10.1126/science.aan4368 | AarF domain-containing protein kinase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Long-chain-fatty-acid--CoA ligase 5 | 1 |
| - | 10.6019/EOS300108 | HepG2 | 1 |
| 29191878 | 10.1126/science.aan4368 | Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 11 | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 10 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL2 | 1 |
Data from ChEMBL 36 via Core Engine